156 related articles for article (PubMed ID: 20884709)
1. Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents.
Fernández de Larrea C; Tovar N; Cibeira MT; Aróstegui JI; Rosiñol L; Elena M; Filella X; Yagüe J; Bladé J
Haematologica; 2011 Jan; 96(1):171-3. PubMed ID: 20884709
[TBL] [Abstract][Full Text] [Related]
2. Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition.
de Larrea CF; Cibeira MT; Elena M; Arostegui JI; Rosiñol L; Rovira M; Filella X; Yagüe J; Bladé J
Blood; 2009 Dec; 114(24):4954-6. PubMed ID: 19797521
[TBL] [Abstract][Full Text] [Related]
3. Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution.
Tovar N; de Larrea CF; Aróstegui JI; Cibeira MT; Rosiñol L; Rovira M; Elena M; Filella X; Yagüe J; Bladé J
Haematologica; 2013 Jul; 98(7):1142-6. PubMed ID: 23645688
[TBL] [Abstract][Full Text] [Related]
4. Oligoclonal reconstitution masquerading as myeloma relapse.
Chim CS; Chan EY
Ann Hematol; 2013 Jun; 92(6):847-8. PubMed ID: 23150202
[No Abstract] [Full Text] [Related]
5. For survival, the emergence of oligoclonal bands after multiple myeloma treatment is less important than achieving complete remission.
Silva LSVD; Crusoe EQ; Souza LRG; Chiattone CS; Hungria VTM
Rev Bras Hematol Hemoter; 2017; 39(4):331-336. PubMed ID: 29150105
[TBL] [Abstract][Full Text] [Related]
6. Significance of oligoclonal bands after stem cell transplantation in multiple myeloma cases.
Liu AJ; Zong H; Yang GZ; Zhai YH; Li LH
Asian Pac J Cancer Prev; 2012; 13(4):1483-6. PubMed ID: 22799352
[TBL] [Abstract][Full Text] [Related]
7. Differential humoral responses against heat-shock proteins after autologous stem cell transplantation in multiple myeloma.
Tovar N; Fernández de Larrea C; Pedrosa F; Aróstegui JI; Cibeira MT; Rosiñol L; Elena M; Filella X; Yagüe J; Bladé J
Ann Hematol; 2014 Jan; 93(1):107-11. PubMed ID: 24218189
[TBL] [Abstract][Full Text] [Related]
8. [The Clinical Significance of Oligoclonal Bands in Patient with Multiple Myeloma].
Liu JH; Fan HS; Yan WQ; Xu JY; Li LN; Xu Y; Yi SH; Zou DH; Qiu LG; An G
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1453-1463. PubMed ID: 36208249
[TBL] [Abstract][Full Text] [Related]
9. Serum free light chains and oligoclonal bands in patients with multiple myeloma and autologous stem cell transplantation.
Alejandre ME; Pavlovsky MA; Remaggi G; Corrado C; Fernandez I; Milone G; Pavlovsky A; Madalena L; Pandolfo M; Facio ML; Bresciani P; Pavlovsky S; Pizzolato MA
Clin Chem Lab Med; 2012 Apr; 50(6):1093-7. PubMed ID: 22706252
[TBL] [Abstract][Full Text] [Related]
10. oligoclonal bands in patients with multiple myeloma: its emergence per se could not be translated to improved survival.
Fujisawa M; Seike K; Fukumoto K; Suehara Y; Fukaya M; Sugihara H; Takeuchi M; Matsue K
Cancer Sci; 2014 Nov; 105(11):1442-6. PubMed ID: 25182124
[TBL] [Abstract][Full Text] [Related]
11. Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival.
Jimenez-Zepeda VH; Reece DE; Trudel S; Franke N; Winter A; Chen C; Tiedemann R; Kukreti V
Leuk Lymphoma; 2014 Oct; 55(10):2284-9. PubMed ID: 24354684
[TBL] [Abstract][Full Text] [Related]
12. Oligoclonal bands and immunoglobulin isotype switch during monitoring of patients with multiple myeloma and autologous hematopoietic cell transplantation: a 16-year experience.
Alejandre ME; Madalena LB; Pavlovsky MA; Facio ML; Corrado C; Milone G; Bresciani PD; Fraind SA; Pavlovsky S; Pizzolato MA
Clin Chem Lab Med; 2010 May; 48(5):727-31. PubMed ID: 20450334
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between emergence of an abnormal protein band or of oligoclonal bands and survival in patients with multiple myeloma achieving complete remission following autologous stem cell transplantation.
Byrne E; Giles C; Andrews J; Rahemtulla A; Naresh KN
Haematologica; 2011 Apr; 96(4):e29. PubMed ID: 21454876
[No Abstract] [Full Text] [Related]
14. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma.
Harousseau JL; Attal M; Divine M; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M; Abgrall JF
Stem Cells; 1995 Aug; 13 Suppl 2():132-9. PubMed ID: 8520502
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-Based Stem Cell Mobilization Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens.
Oyekunle A; Shumilov E; Kostrewa P; Burchert A; Trümper L; Wuchter P; Wulf G; Bacher U; Kröger N
Biol Blood Marrow Transplant; 2018 Feb; 24(2):276-281. PubMed ID: 29037891
[TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation.
Hovenga S; de Wolf JT; Guikema JE; Klip H; Smit JW; Smit Sibinga CT; Bos NA; Vellenga E
Bone Marrow Transplant; 2000 Apr; 25(7):723-8. PubMed ID: 10745257
[TBL] [Abstract][Full Text] [Related]
17. Impact of Autologous Stem Cell Transplantation on the Incidence and Outcome of Oligoclonal Bands in Patients with Light-Chain Amyloidosis.
Rodríguez-Lobato LG; Fernández de Larrea C; Cibeira MT; Tovar N; Aróstegui JI; Rosiñol L; Díaz T; Lozano E; Elena M; Yagüe J; Bladé J
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1269-1275. PubMed ID: 28434927
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.
Cavo M; Tacchetti P; Patriarca F; Petrucci MT; Pantani L; Galli M; Di Raimondo F; Crippa C; Zamagni E; Palumbo A; Offidani M; Corradini P; Narni F; Spadano A; Pescosta N; Deliliers GL; Ledda A; Cellini C; Caravita T; Tosi P; Baccarani M;
Lancet; 2010 Dec; 376(9758):2075-85. PubMed ID: 21146205
[TBL] [Abstract][Full Text] [Related]
19. Emergence of Oligoclonal Bands in Association with the use of Chemotherapy and Hematopoietic Stem Cell Transplantation.
Paul C; Chakraborty S; Chakraborty S
Indian J Clin Biochem; 2022 Jul; 37(3):328-334. PubMed ID: 35873608
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the Intergroupe Francophone du Myélome (IFM).
Yakoub-Agha I; Attal M; Dumontet C; Delannoy V; Moreau P; Berthou C; Lamy T; Grosbois B; Dauriac C; Dorvaux V; Bay JO; Monconduit M; Harousseau JL; Duguet C; Duhamel A; Facon T
Hematol J; 2002; 3(4):185-92. PubMed ID: 12189564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
